Adlai Nortye Group Ltd. (ANL)
NASDAQ: ANL · Real-Time Price · USD
9.06
+0.32 (3.66%)
Nov 19, 2026, 4:00 PM EST - Market closed
Adlai Nortye Group Employees
Adlai Nortye Group had 109 employees as of December 31, 2025. The number of employees decreased by 14 or 11.38% compared to the previous year. That makes Adlai Nortye Group the 30,947th largest employer in the world and 3,928th in the United States.
Employees
109
Change (1Y)
-14
Growth (1Y)
-11.38%
Revenue / Employee
$165,651
Profits / Employee
-$206,688
Market Cap
583.45M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 109 | -14 | -11.38% |
| Dec 31, 2024 | 123 | -4 | -3.15% |
| Dec 31, 2023 | 127 | -2 | -1.55% |
| Jun 30, 2023 | 130 | - | - |
| Mar 31, 2023 | 129 | - | - |
| Dec 31, 2022 | 129 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Geron | 258 |
| Alumis | 253 |
| 4D Molecular Therapeutics | 196 |
| DBV Technologies | 179 |
| Olema Oncology | 150 |
| Cullinan Therapeutics | 109 |
| Bicara Therapeutics | 103 |
| Design Therapeutics | 60 |
ANL News
- 2 days ago - Adlai Nortye Group Transcript: Jefferies Global Healthcare Conference - Transcripts
- 23 days ago - Adlai Nortye Announces Oral Presentation for AN4035 Program Update at the Upcoming 38th EORTC-NCI-AACR Symposium - GlobeNewsWire
- 5 weeks ago - Adlai Nortye enters CTCSAs with Eli Lilly, Merck KGaA for cetuximab - TheFly
- 5 weeks ago - Adlai Nortye Enters into Clinical Collaboration with Lilly and Merck KGaA, Darmstadt, Germany to Evaluate Combination of AN4035 and Cetuximab - GlobeNewsWire
- 7 weeks ago - Adlai Nortye appoints Liu as Head of Investor Relations, Public Relations - TheFly
- 7 weeks ago - Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations - GlobeNewsWire
- 2 months ago - Adlai Nortye Group Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts
- 2 months ago - Adlai Nortye initiated with a Buy at Jefferies - TheFly